Upstate Active Clinical Trials

Study Title:

58-Week Open-label Trial of Tavapadon in Parkinson’s Disease (TEMPO-4 Trial)

What is the purpose of the study? (in Layman's terms, please describe the study)

To evaluate the safety and tolerability of long-term administration of tavapadon in subjects with PD.

Upstate Institutional Review Board (IRB) Number:

1670828

Patient Age Group:

Adults

Principal Investigator:

Dragos L Mihaila

What is involved if I participate?

• How long is the study?
  Approximately 14 months.

ClinicalTrials.Gov ID:

NCT04760769

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Marielle N Posmik
Phone: 315-464-1670
Email: [email protected]

Return to Previous Page || Search Again